The Recall Desk
SevereFDA (Drugs)·D-231-2013·Announced 2013-04-10

FDA Recalls Unapproved Nootropa Cognitive Enhancement Supplement

Palmer Natural Products is recalling Nootropa Cognitive Enhancement Supplement because it was marketed without an approved NDA/ANDA.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class II, which corresponds to a severity score of 4 (Severe) per the rubric.

Plain-English summary

Palmer Natural Products is recalling Nootropa Cognitive Enhancement Supplement, 400 mg Aniracetam Capsules, 60 count bottle. The recall involves 672 bottles of the product.

The FDA is recalling the product because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), making it an unapproved drug.

The product was distributed in Florida, Idaho, California, and Hong Kong, and can be ordered online. Consumers should stop using the product and contact the recalling firm for instructions.

The recalled product

Product
NOOTROPA COGNITIVE ENHANCEMENT SUPPLEMENT, 400 mg Aniracetam Capsules 60 count bottle, OTC Manufactured & Packaged in the USA for NOOTROPA.COM. DEVELOPED BY: Digital Superfuture Limited Arntel Building 9B 148 Des Voeux Rd. Hong Kong.
Affected units
672

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot HJLA

Distribution

Distributed in 3 states:

Part of a larger recall action

This product is one of 7 recalled by Palmer Natural Products under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →

Same manufacturer · Palmer Natural Products

See all →